$NBY NovaBay Pharmaceuticals, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovaBay Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in NovaBay Pharmaceuticals, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
NovaBay Pharmaceuticals, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Anderson Mark Brian | CSO | 0 | 0 | Nov 01 2011 | |||
| Bley Keith R | SVP Product Development | 0 | 0 | Sep 30 2014 | |||
| Cashion Charles | Director | 29,522 | 116,612 | Jan 06 2015 | |||
| China Pioneer Pharma Holdings Ltd | 10% Owner | 108,156 | 427,216 | Dec 02 2013 | |||
| China Pioneer Pharma Holdings Ltd | 10% Owner | 608,156 | 2,402,216 | May 14 2014 | |||
| Dailley Anthony | Director | 285,259 | 1,126,773 | Mar 21 2014 | |||
| Dailley Anthony | Director | 161,047 | 636,136 | Sep 03 2008 | |||
| Dailley Anthony | Director | 191,079 | 754,762 | Jan 05 2010 | |||
| Freiman Paul E. | Director | 45,137 | 178,291 | May 29 2020 | |||
| Freiman Paul E. | Director | 26,137 | 103,241 | Jan 05 2010 | |||
| Freiman Paul E. | Director | 12,137 | 47,941 | Aug 18 2010 | |||
| Fu Jian Ping | 10% Owner | 4,000,000 | 15,800,000 | Aug 04 2020 | |||
| Hall Justin | CEO and GC | 0 | 0 | Aug 24 2020 | |||
| HIXSON HARRY F JR | Director | 30,260 | 119,527 | Jan 05 2010 | |||
| Hoon Russell A. | Senior Vice President | 0 | 0 | Apr 15 2015 | |||
| Jones Andrew D. | CFO | 82,006 | 323,924 | May 07 2021 | |||
| Khosrovi Behzad | SVP Product Development | 136,000 | 537,200 | Jan 14 2013 | |||
| Khosrovi Behzad | VP Research and Development | 0 | 0 | Sep 09 2008 | |||
| Khosrovi Behzad | SVP Product Development & CAO | 0 | 0 | Nov 15 2010 | |||
| Li Xinzhou | Director | 2,000,000 | 7,900,000 | May 29 2020 | |||
| Li Xinzhou | 10% Owner | 2,120,000 | 8,374,000 | Jan 03 2013 | |||
| Li Xinzhou | 10% Owner | 2,001,743 | 7,906,885 | Dec 02 2013 | |||
| LIU XIAOYAN | Director | 0 | 0 | Jan 04 2017 | |||
| Liu Yanbin | Director | 0 | 0 | Jun 04 2018 | |||
| Ma Yonghao | Director | 0 | 0 | Jun 04 2018 | |||
| Maderis Gail J | Director | 0 | 0 | Oct 28 2019 | |||
| Maderis Gail J | Director | 0 | 0 | Jan 06 2015 | |||
| McGovern John Joseph | Int Pres, CEO, CFO & Treasurer | 0 | 0 | Oct 11 2018 | |||
| McPherson T. Alex | Director | 6,700 | 26,465 | Jan 06 2016 | |||
| McPherson T. Alex | Director | 37,693 | 148,887 | Jan 05 2010 | |||
| Najafi Ramin | Chief Executive Officer | 12,000 | 47,400 | Aug 21 2015 | |||
| Najafi Ramin | Chief Executive Officer | 7,200 | 28,440 | Sep 02 2008 | |||
| Najafi Ramin | Cheif Executive Officer | 0 | 0 | Sep 09 2008 | |||
| Najafi Ramin | Chief Executive Officer | 0 | 0 | Nov 15 2010 | |||
| NAQU AREA PIONEER PHARMA CO., LTD. | 10% Owner | 2,000,000 | 7,900,000 | Nov 20 2012 | |||
| O'Reilly John James | Chief Financial Officer | 0 | 0 | Dec 18 2007 | |||
| O'Reilly John James | SVP Business and Corporate Dev | 0 | 0 | Sep 09 2008 | |||
| PAULSON THOMAS J | CFO | 142,196 | 561,674 | Jan 26 2017 | |||
| PAULSON THOMAS J | CFO | 2,000 | 7,900 | Nov 15 2010 | |||
| PAULSON THOMAS J | Chief Financial Officer | 0 | 0 | Sep 09 2008 | |||
| PAULSON THOMAS J | CFO | 4,000 | 15,800 | Sep 12 2008 | |||
| PAULSON THOMAS J | CFO | 68,210 | 269,430 | Dec 15 2014 | |||
| Pioneer Pharma (Hong Kong) Co Ltd | 10% Owner | 5,188,421 | 20,494,263 | Jun 13 2019 | |||
| Pioneer Pharma (Hong Kong) Co Ltd | 10% Owner | 7,005,656 | 27,672,341 | Dec 04 2013 | |||
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 3,879,519 | 15,324,100 | Sep 26 2016 | |||
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 7,005,656 | 27,672,341 | Dec 04 2013 | |||
| Radaelli Massimo | Director | 0 | 0 | Jan 06 2016 | |||
| Radaelli Massimo | Director | 0 | 0 | Jan 06 2015 | |||
| Raleigh Jason Philip | Interim CFO and Treasurer | 0 | 0 | Jun 12 2019 | |||
| Scott Colin | VP, Clinical Research and Deve | 0 | 0 | Sep 09 2008 | |||
| SIECZKAREK MARK M | Director | 1,156,883 | 4,569,688 | Oct 28 2019 | |||
| SIECZKAREK MARK M | Director | 29,800 | 117,710 | Jan 06 2015 | |||
| Stroman David W. | SVP, Ophthalmic Product Devt. | 23,000 | 90,850 | Oct 06 2015 | |||
| STUART LEWIS J | Chief Commercial Officer | 0 | 0 | Jan 08 2018 | |||
| Tufts Robert R. | Director | 348,408 | 1,376,212 | Jan 31 2014 | |||
| Wang Xiaopei | Director | 0 | 0 | May 29 2020 | |||
| Wicks Tony D.S. | Director | 0 | 0 | Jan 06 2015 | |||
| Wicks Tony D.S. | Director | 140,657 | 555,595 | Aug 26 2008 | |||
| Wicks Tony D.S. | Director | 161,690 | 638,676 | Jan 05 2010 | |||
| WU MIJIA | Director | 20,000 | 79,000 | Aug 19 2020 | |||
| WU ROY J | SVP Bus & Corp Development | 19,296 | 76,219 | Oct 06 2015 | |||
| WU ROY J | SVP Bus & Corp Development | 0 | 0 | Sep 30 2014 | |||
| Xu Wang | NEO - Sr Mgr and Controller | 0 | 0 | Aug 24 2020 | |||
| Zavodnick Todd Erik | Director | 0 | 0 | Oct 30 2019 | |||
| Zheng Yenyou | Director | 0 | 0 | May 29 2020 |